Literature DB >> 24682771

Good's syndrome, CVID, and selective antibody deficiency in patients with chronic rhinosinusitis.

Marianne Frieri1.   

Abstract

Good's syndrome and common variable immune deficiency (CVID) are associated with chronic rhinosinusitis. Good's syndrome is characterized by hypogammaglobulinemia, B-cell depletion, variable defects in cellular immunity and thymoma. Immunodeficiency and recurrent infections can initially present after thymectomy. The pathogenesis can involve cytokines from bone marrow along with genetic defects. Intravenous gamma globulin (IVIG) restores defective signaling and can reestablish immune homeostasis. IVIG at regular intervals is the most effective way to improve the clinical symptoms and reduce patient mortality. Increased awareness of the clinical and immunological profile of this syndrome may increase its early recognition. CVID patients have hypogammaglobulinemia, respond to IVIG and have a dysregulated antimicrobial peptide response to pathogenic bacteria in the upper respiratory tract. This article reviewed selected literature on Good's syndrome, described an unusual case of Good's syndrome, CVID including SAD related to chronic rhinosinusitis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24682771     DOI: 10.1007/s11882-014-0438-4

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  36 in total

1.  T lymphocytes constitutively produce an interferonlike cytokine limitin characterized as a heat- and acid-stable and heparin-binding glycoprotein.

Authors:  Kenji Oritani; Seiichi Hirota; Taishirou Nakagawa; Isao Takahashi; Shin-Ichiro Kawamoto; Masahide Yamada; Naoko Ishida; Toshihiko Kadoya; Yoshiaki Tomiyama; Paul W Kincade; Yuji Matsuzawa
Journal:  Blood       Date:  2002-06-28       Impact factor: 22.113

2.  Association between severity of asthma and degree of chronic rhinosinusitis.

Authors:  David C Lin; Rakesh K Chandra; Bruce K Tan; Whitney Zirkle; David B Conley; Leslie C Grammer; Robert C Kern; Robert P Schleimer; Anju T Peters
Journal:  Am J Rhinol Allergy       Date:  2011 Jul-Aug       Impact factor: 2.467

Review 3.  Primary immune deficiencies affecting lymphocyte differentiation: lessons from the spectrum of resulting infections.

Authors:  Matthew C Cook; Stuart G Tangye
Journal:  Int Immunol       Date:  2009-08-03       Impact factor: 4.823

Review 4.  Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature.

Authors:  P E Tarr; M C Sneller; L J Mechanic; A Economides; C M Eger; W Strober; C Cunningham-Rundles; D R Lucey
Journal:  Medicine (Baltimore)       Date:  2001-03       Impact factor: 1.889

Review 5.  Controversies in IgG replacement therapy in patients with antibody deficiency diseases.

Authors:  Erwin W Gelfand; Hans D Ochs; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2013-04       Impact factor: 10.793

Review 6.  Perspectives on common variable immune deficiency.

Authors:  Joon H Park; Elena S Resnick; Charlotte Cunningham-Rundles
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

7.  Decreased SPLUNC1 expression is associated with Pseudomonas infection in surgically treated chronic rhinosinusitis patients who may require repeated sinus surgery.

Authors:  Yung-An Tsou; Chuan-Mu Chen; Tzu-Chieh Lin; Fang-Wei Hu; Chin-Jann Tai; Hui-Chen Chen; Te-Huei Yeh; Horng-Jyh Harn; Ming-Hsui Tsai; Chia-Ing Jan
Journal:  Laryngoscope       Date:  2013-01-31       Impact factor: 3.325

Review 8.  Antibody deficiency in chronic rhinosinusitis: epidemiology and burden of illness.

Authors:  Christopher J Ocampo; Anju T Peters
Journal:  Am J Rhinol Allergy       Date:  2013-01       Impact factor: 2.467

Review 9.  Assessment and clinical interpretation of polysaccharide antibody responses.

Authors:  Kenneth Paris; Ricardo U Sorensen
Journal:  Ann Allergy Asthma Immunol       Date:  2007-11       Impact factor: 6.347

10.  Impaired release of antimicrobial peptides into nasal fluid of hyper-IgE and CVID patients.

Authors:  Andreas Cederlund; Marie Olliver; Rokeya Sultana Rekha; Monica Lindh; Lennart Lindbom; Staffan Normark; Birgitta Henriques-Normark; Jan Andersson; Birgitta Agerberth; Peter Bergman
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

View more
  2 in total

Review 1.  Humoral Primary Immunodeficiencies in Chronic Rhinosinusitis.

Authors:  Smriti Nayan; Reza Alizadehfar; Martin Desrosiers
Journal:  Curr Allergy Asthma Rep       Date:  2015-08       Impact factor: 4.806

Review 2.  Aeroallergens, air pollutants, and chronic rhinitis and rhinosinusitis.

Authors:  Nyall R London; Ioan Lina; Murugappan Ramanathan
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2018-11-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.